October 27, 2022 (Investorideas.com Newswire) According to TradingPlatforms.com, Crypto applications deployments on Ethereum are up 143% YoY in Q3’22.
Speaking on the data, TradingPlatforms specialist Edith Reads said. “Ethereum merge was a calculated move. It has seen Ethereum gain bullish characteristics from a distance, rising by 31%. Besides, the YoY increase in crypto application deployment shows that Ethereum is holding right. This is the right time to invest in cryptocurrency as the odds change.”
A generally optimistic news flow supported the upward price trends of cryptocurrencies. The White House released the first-ever “complete framework” on cryptos on the regulatory front. Besides, Congress made significant advancements in the direction of meaningful stablecoin regulations. Several blockchains achieved significant technological milestones in the meanwhile.
The positivity on cryptocurrencies is not limited to Ethereum. Other cryptos are also showing strengths against the dollar.
Blockchain Has Huge Potential in Healthcare
Blockchain applies to a variety of purposes in the healthcare industry. The systems have shown the ability to lower healthcare expenses. Besides, it increases stakeholder access to information and simplifies business procedures.
The system controls the drug supply chain and facilitates the safe transfer of patient medical records. Moreover, it simplifies the transfer of patient medical records. The ledger technology assists healthcare researchers in deciphering genetic code. The full story and statistics can be found here: Crypto Applications Deployments on Ethereum Are up 143% YoY in Q3’22
This news is published on the Investorideas.com Newswire – a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions.
More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com